Sexual Dimorphism in Clinical Subtypes, Biomarkers and Disease Progression of Parkinson’s Disease
Objective: To investigate differences in clinical subtypes, biomarkers, and course of progression in Parkinson’s disease (PD) between the two biological sexes. Background: PD is a…Comprehensive Strategy for Increasing Clinical Research Participation of Black and Hispanic Patients with Parkinsonism
Objective: To implement and test a multidimensional strategy for increasing racial and ethnic diversity in parkinsonism research. Background: Diversity in research participation is critical for…What you should know about your patient.
Objective: Support understanding of concerns of the Lesbian, Gay, Bisexual, Transgender Intersex, Queer +(LGBTIQ+) community and how they impact on health professional interactions Background: 9-10%…Scoping Review of Caregiver Burden in Parkinson’s Disease
Objective: To evaluate caregiver burden and stress in Parkinson’s disease and factors that may influence different burden and stress levels. Background: N/A Method: A systematic…Bedside Assessment of Downgaze Palsy by Amplitude in Patients with Progressive Supranuclear Palsy
Objective: To assess the specificity and reliability of the bedside assessment of downgaze palsy by amplitude based on the upper edge of the iris relative to…Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites
Objective: We aim to examine the impact of ambient temperature fluctuations on Parkinson’s disease (PD) patients across two distinct climates. Background: PD is a neurodegenerative…Vestibular impairment, turning direction and turn progression in Parkinson’s disease
Objective: To explore the correlation between the Romberg test condition 4 and turn progression in most affected and least affected body side directions in people…Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders
Objective: To describe factors associated with triggering a best practice advisory (BPA) for dopamine-blocking agents (DBA) and report preliminary outcomes in hospitalized persons with Parkinson’s…Walking reduced the risk of Parkinson’s disease dementia: a retrospective longitudinal follow-up study
Objective: We aimed to test whether the minimal amount of exercise (MAE) of walking, which is practical for people with motor dysfunction, could help prevent…Cognitive Impairment in a Cohort of Patients with DBS for parkinson’s disease treatment from a multicentric Cohort in Colombia
Objective: The objective of the present work is to investigate the clinical outcomes related to cognitive performance in Colombian patients with DBS treatment. Background: Parkinson's…
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 338
- Next Page »